TABLE 4.
Renal denervation (n = 11) | Spironolactone (n = 13) | |||
Variable | Change (Δ) at 6 months, mean (95% CI) | Change (Δ) at 6 months Mean (95% CI) | Mean baseline-adjusted difference (95% CI) between the two groups at 6 months (spironolactone versus RDN) | p |
Serum creatinine (μmol/l) | 5.9 (−2.3 to 14.1) | 14.9 (7.4–22.4) | 9.0 (−2.5 to 20.4) | 0.1 |
eGFR (ml/min per 1.73 m2) | −3.0 (−9.8 to 3.9) | −13.7 (−20.0 to −7.4) | −10.7 (−20.1 to −1.4) | 0.03 |
Serum potassium (mmol/l) | −0.13 (−0.36 to 0.11) | 0.81 (0.60–1.03) | 0.94 (0.62–1.25) | <0.001 |
CI, confidence intervals; eGFR, estimated glomerular filtration rate; RDN, renal denervation.